潰瘍性大腸炎の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Ulcerative Colitis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8106697)・商品コード:GIR8106697
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月1日
・ページ数:124
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、潰瘍性大腸炎の世界市場について調べ、まとめました。種類別セグメントは、経口、注射等、用途別セグメントは、病院、ドラッグストア等に区分しました。潰瘍性大腸炎の世界市場概観、メーカー動向、メーカー別潰瘍性大腸炎シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・潰瘍性大腸炎の市場概観
・潰瘍性大腸炎のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・潰瘍性大腸炎のメーカー別販売動向、市場シェア、市場集中度、競争動向
・潰瘍性大腸炎の世界市場規模
・潰瘍性大腸炎の北米市場分析(アメリカ、カナダ、メキシコ等)
・潰瘍性大腸炎のアメリカ市場規模推移
・潰瘍性大腸炎のカナダ市場規模推移
・潰瘍性大腸炎のメキシコ市場規模推移
・潰瘍性大腸炎のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・潰瘍性大腸炎のドイツ市場規模推移
・潰瘍性大腸炎のイギリス市場規模推移
・潰瘍性大腸炎のロシア市場規模推移
・潰瘍性大腸炎のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・潰瘍性大腸炎の日本市場規模推移
・潰瘍性大腸炎の中国市場規模推移
・潰瘍性大腸炎の韓国市場規模推移
・潰瘍性大腸炎のインド市場規模推移
・潰瘍性大腸炎の東南アジア市場規模推移
・潰瘍性大腸炎の南米市場分析(ブラジル、アルゼンチン等)
・潰瘍性大腸炎の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・潰瘍性大腸炎の種類別分析/市場規模推移(経口、注射)
・潰瘍性大腸炎の用途別分析/市場規模推移(病院、ドラッグストア)
・潰瘍性大腸炎の市場予測(地域別予測、種類別予測、用途別予測)
・潰瘍性大腸炎の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum).

Scope of the Report:

This report focuses on the Ulcerative Colitis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Ulcerative Colitis is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Johnson & Johnson.

AbbVie

Takeda Pharmaceuticals

Roche

Warner Chilcott

Salix Pharmaceuticals/Santarus

Shire Pharmaceuticals

Ferring Pharmaceuticals

Pfizer

InDeX Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Oral

Injection

Market Segment by Applications, can be divided into

Hospital

Drugs Stores

There are 15 Chapters to deeply display the global Ulcerative Colitis market.

Chapter 1, to describe Ulcerative Colitis Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Ulcerative Colitis, with sales, revenue, and price of Ulcerative Colitis, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Ulcerative Colitis, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Ulcerative Colitis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Ulcerative Colitis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents

1 Market Overview

1.1 Ulcerative Colitis Introduction

1.2 Market Analysis by Type

1.2.1 Oral

1.2.2 Injection

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Drugs Stores

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Johnson & Johnson.

2.1.1 Business Overview

2.1.2 Ulcerative Colitis Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Johnson & Johnson. Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 AbbVie

2.2.1 Business Overview

2.2.2 Ulcerative Colitis Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AbbVie Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Takeda Pharmaceuticals

2.3.1 Business Overview

2.3.2 Ulcerative Colitis Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Takeda Pharmaceuticals Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Roche

2.4.1 Business Overview

2.4.2 Ulcerative Colitis Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Roche Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Warner Chilcott

2.5.1 Business Overview

2.5.2 Ulcerative Colitis Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Warner Chilcott Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Salix Pharmaceuticals/Santarus

2.6.1 Business Overview

2.6.2 Ulcerative Colitis Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Shire Pharmaceuticals

2.7.1 Business Overview

2.7.2 Ulcerative Colitis Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Shire Pharmaceuticals Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Ferring Pharmaceuticals

2.8.1 Business Overview

2.8.2 Ulcerative Colitis Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Ferring Pharmaceuticals Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Pfizer

2.9.1 Business Overview

2.9.2 Ulcerative Colitis Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Pfizer Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 InDeX Pharmaceuticals

2.10.1 Business Overview

2.10.2 Ulcerative Colitis Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 InDeX Pharmaceuticals Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Ulcerative Colitis Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Ulcerative Colitis Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Ulcerative Colitis Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Ulcerative Colitis Manufacturer Market Share in 2017

3.3.2 Top 6 Ulcerative Colitis Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Ulcerative Colitis Market Analysis by Regions

4.1 Global Ulcerative Colitis Sales, Revenue and Market Share by Regions

4.1.1 Global Ulcerative Colitis Sales and Market Share by Regions (2013-2018)

4.1.2 Global Ulcerative Colitis Revenue and Market Share by Regions (2013-2018)

4.2 North America Ulcerative Colitis Sales and Growth Rate (2013-2018)

4.3 Europe Ulcerative Colitis Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Ulcerative Colitis Sales and Growth Rate (2013-2018)

4.5 South America Ulcerative Colitis Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Ulcerative Colitis Sales and Growth Rate (2013-2018)

5 North America Ulcerative Colitis by Countries

5.1 North America Ulcerative Colitis Sales, Revenue and Market Share by Countries

5.1.1 North America Ulcerative Colitis Sales and Market Share by Countries (2013-2018)

5.1.2 North America Ulcerative Colitis Revenue and Market Share by Countries (2013-2018)

5.2 United States Ulcerative Colitis Sales and Growth Rate (2013-2018)

5.3 Canada Ulcerative Colitis Sales and Growth Rate (2013-2018)

5.4 Mexico Ulcerative Colitis Sales and Growth Rate (2013-2018)

6 Europe Ulcerative Colitis by Countries

6.1 Europe Ulcerative Colitis Sales, Revenue and Market Share by Countries

6.1.1 Europe Ulcerative Colitis Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Ulcerative Colitis Revenue and Market Share by Countries (2013-2018)

6.2 Germany Ulcerative Colitis Sales and Growth Rate (2013-2018)

6.3 UK Ulcerative Colitis Sales and Growth Rate (2013-2018)

6.4 France Ulcerative Colitis Sales and Growth Rate (2013-2018)

6.5 Russia Ulcerative Colitis Sales and Growth Rate (2013-2018)

6.6 Italy Ulcerative Colitis Sales and Growth Rate (2013-2018)

7 Asia-Pacific Ulcerative Colitis by Countries

7.1 Asia-Pacific Ulcerative Colitis Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Ulcerative Colitis Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Ulcerative Colitis Revenue and Market Share by Countries (2013-2018)

7.2 China Ulcerative Colitis Sales and Growth Rate (2013-2018)

7.3 Japan Ulcerative Colitis Sales and Growth Rate (2013-2018)

7.4 Korea Ulcerative Colitis Sales and Growth Rate (2013-2018)

7.5 India Ulcerative Colitis Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Ulcerative Colitis Sales and Growth Rate (2013-2018)

8 South America Ulcerative Colitis by Countries

8.1 South America Ulcerative Colitis Sales, Revenue and Market Share by Countries

8.1.1 South America Ulcerative Colitis Sales and Market Share by Countries (2013-2018)

8.1.2 South America Ulcerative Colitis Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Ulcerative Colitis Sales and Growth Rate (2013-2018)

8.3 Argentina Ulcerative Colitis Sales and Growth Rate (2013-2018)

8.4 Colombia Ulcerative Colitis Sales and Growth Rate (2013-2018)

9 Middle East and Africa Ulcerative Colitis by Countries

9.1 Middle East and Africa Ulcerative Colitis Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Ulcerative Colitis Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Ulcerative Colitis Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Ulcerative Colitis Sales and Growth Rate (2013-2018)

9.3 UAE Ulcerative Colitis Sales and Growth Rate (2013-2018)

9.4 Egypt Ulcerative Colitis Sales and Growth Rate (2013-2018)

9.5 Nigeria Ulcerative Colitis Sales and Growth Rate (2013-2018)

9.6 South Africa Ulcerative Colitis Sales and Growth Rate (2013-2018)

10 Global Ulcerative Colitis Market Segment by Type

10.1 Global Ulcerative Colitis Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Ulcerative Colitis Sales and Market Share by Type (2013-2018)

10.1.2 Global Ulcerative Colitis Revenue and Market Share by Type (2013-2018)

10.2 Oral Sales Growth and Price

10.2.1 Global Oral Sales Growth (2013-2018)

10.2.2 Global Oral Price (2013-2018)

10.3 Injection Sales Growth and Price

10.3.1 Global Injection Sales Growth (2013-2018)

10.3.2 Global Injection Price (2013-2018)

11 Global Ulcerative Colitis Market Segment by Application

11.1 Global Ulcerative Colitis Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Drugs Stores Sales Growth (2013-2018)

12 Ulcerative Colitis Market Forecast (2018-2023)

12.1 Global Ulcerative Colitis Sales, Revenue and Growth Rate (2018-2023)

12.2 Ulcerative Colitis Market Forecast by Regions (2018-2023)

12.2.1 North America Ulcerative Colitis Market Forecast (2018-2023)

12.2.2 Europe Ulcerative Colitis Market Forecast (2018-2023)

12.2.3 Asia-Pacific Ulcerative Colitis Market Forecast (2018-2023)

12.2.4 South America Ulcerative Colitis Market Forecast (2018-2023)

12.2.5 Middle East and Africa Ulcerative Colitis Market Forecast (2018-2023)

12.3 Ulcerative Colitis Market Forecast by Type (2018-2023)

12.3.1 Global Ulcerative Colitis Sales Forecast by Type (2018-2023)

12.3.2 Global Ulcerative Colitis Market Share Forecast by Type (2018-2023)

12.4 Ulcerative Colitis Market Forecast by Application (2018-2023)

12.4.1 Global Ulcerative Colitis Sales Forecast by Application (2018-2023)

12.4.2 Global Ulcerative Colitis Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures



Figure Ulcerative Colitis Picture

Table Product Specifications of Ulcerative Colitis

Figure Global Sales Market Share of Ulcerative Colitis by Types in 2017

Table Ulcerative Colitis Types for Major Manufacturers

Figure Oral Picture

Figure Injection Picture

Figure Ulcerative Colitis Sales Market Share by Applications in 2017

Figure Hospital Picture

Figure Drugs Stores Picture

Figure United States Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure France Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure UK Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure China Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure India Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Ulcerative Colitis Revenue (Value) and Growth Rate (2013-2023)

Table Johnson & Johnson. Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson. Ulcerative Colitis Type and Applications

Table Johnson & Johnson. Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Ulcerative Colitis Type and Applications

Table AbbVie Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Takeda Pharmaceuticals Ulcerative Colitis Type and Applications

Table Takeda Pharmaceuticals Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Ulcerative Colitis Type and Applications

Table Roche Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Warner Chilcott Basic Information, Manufacturing Base and Competitors

Table Warner Chilcott Ulcerative Colitis Type and Applications

Table Warner Chilcott Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Salix Pharmaceuticals/Santarus Basic Information, Manufacturing Base and Competitors

Table Salix Pharmaceuticals/Santarus Ulcerative Colitis Type and Applications

Table Salix Pharmaceuticals/Santarus Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Shire Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Shire Pharmaceuticals Ulcerative Colitis Type and Applications

Table Shire Pharmaceuticals Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Ferring Pharmaceuticals Ulcerative Colitis Type and Applications

Table Ferring Pharmaceuticals Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Ulcerative Colitis Type and Applications

Table Pfizer Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table InDeX Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table InDeX Pharmaceuticals Ulcerative Colitis Type and Applications

Table InDeX Pharmaceuticals Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Ulcerative Colitis Sales by Manufacturer (2016-2017)

Figure Global Ulcerative Colitis Sales Market Share by Manufacturer in 2016

Figure Global Ulcerative Colitis Sales Market Share by Manufacturer in 2017

Table Global Ulcerative Colitis Revenue by Manufacturer (2016-2017)

Figure Global Ulcerative Colitis Revenue Market Share by Manufacturer in 2016

Figure Global Ulcerative Colitis Revenue Market Share by Manufacturer in 2017

Figure Top 3 Ulcerative Colitis Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Ulcerative Colitis Manufacturer (Revenue) Market Share in 2017

Figure Global Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Global Ulcerative Colitis Revenue and Growth Rate (2013-2018)

Table Global Ulcerative Colitis Sales by Regions (2013-2018)

Table Global Ulcerative Colitis Sales Market Share by Regions (2013-2018)

Table Global Ulcerative Colitis Revenue by Regions (2013-2018)

Figure Global Ulcerative Colitis Revenue Market Share by Regions in 2013

Figure Global Ulcerative Colitis Revenue Market Share by Regions in 2017

Figure North America Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Europe Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure South America Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure North America Ulcerative Colitis Revenue and Growth Rate (2013-2018)

Table North America Ulcerative Colitis Sales by Countries (2013-2018)

Table North America Ulcerative Colitis Sales Market Share by Countries (2013-2018)

Figure North America Ulcerative Colitis Sales Market Share by Countries in 2013

Figure North America Ulcerative Colitis Sales Market Share by Countries in 2017

Table North America Ulcerative Colitis Revenue by Countries (2013-2018)

Table North America Ulcerative Colitis Revenue Market Share by Countries (2013-2018)

Figure North America Ulcerative Colitis Revenue Market Share by Countries in 2013

Figure North America Ulcerative Colitis Revenue Market Share by Countries in 2017

Figure United States Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Canada Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Mexico Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Europe Ulcerative Colitis Revenue and Growth Rate (2013-2018)

Table Europe Ulcerative Colitis Sales by Countries (2013-2018)

Table Europe Ulcerative Colitis Sales Market Share by Countries (2013-2018)

Table Europe Ulcerative Colitis Revenue by Countries (2013-2018)

Figure Europe Ulcerative Colitis Revenue Market Share by Countries in 2016

Figure Europe Ulcerative Colitis Revenue Market Share by Countries in 2017

Figure Germany Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure UK Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure France Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Russia Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Italy Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Ulcerative Colitis Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Ulcerative Colitis Sales by Countries (2013-2018)

Table Asia-Pacific Ulcerative Colitis Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Ulcerative Colitis Sales Market Share by Countries 2017

Table Asia-Pacific Ulcerative Colitis Revenue by Countries (2013-2018)

Figure Asia-Pacific Ulcerative Colitis Revenue Market Share by Countries 2017

Figure China Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Japan Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Korea Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure India Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Southeast Asia Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure South America Ulcerative Colitis Revenue and Growth Rate (2013-2018)

Table South America Ulcerative Colitis Sales by Countries (2013-2018)

Table South America Ulcerative Colitis Sales Market Share by Countries (2013-2018)

Figure South America Ulcerative Colitis Sales Market Share by Countries in 2017

Table South America Ulcerative Colitis Revenue by Countries (2013-2018)

Table South America Ulcerative Colitis Revenue Market Share by Countries (2013-2018)

Figure South America Ulcerative Colitis Revenue Market Share by Countries in 2017

Figure Brazil Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Argentina Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Colombia Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Ulcerative Colitis Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Ulcerative Colitis Sales by Countries (2013-2018)

Table Middle East and Africa Ulcerative Colitis Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Ulcerative Colitis Sales Market Share by Countries in 2017

Table Middle East and Africa Ulcerative Colitis Revenue by Countries (2013-2018)

Table Middle East and Africa Ulcerative Colitis Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Ulcerative Colitis Revenue Market Share by Countries in 2013

Figure Middle East and Africa Ulcerative Colitis Revenue Market Share by Countries in 2017

Figure Saudi Arabia Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure UAE Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Egypt Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure Nigeria Ulcerative Colitis Sales and Growth Rate (2013-2018)

Figure South Africa Ulcerative Colitis Sales and Growth Rate (2013-2018)

Table Global Ulcerative Colitis Sales by Type (2013-2018)

Table Global Ulcerative Colitis Sales Share by Type (2013-2018)

Table Global Ulcerative Colitis Revenue by Type (2013-2018)

Table Global Ulcerative Colitis Revenue Share by Type (2013-2018)

Figure Global Oral Sales Growth (2013-2018)

Figure Global Oral Price (2013-2018)

Figure Global Injection Sales Growth (2013-2018)

Figure Global Injection Price (2013-2018)

Table Global Ulcerative Colitis Sales by Application (2013-2018)

Table Global Ulcerative Colitis Sales Share by Application (2013-2018)

Figure Global Drugs Stores Sales Growth (2013-2018)

Figure Global Ulcerative Colitis Sales, Revenue and Growth Rate (2018-2023)

Table Global Ulcerative Colitis Sales Forecast by Regions (2018-2023)

Table Global Ulcerative Colitis Market Share Forecast by Regions (2018-2023)

Figure North America Sales Ulcerative Colitis Market Forecast (2018-2023)

Figure Europe Sales Ulcerative Colitis Market Forecast (2018-2023)

Figure Asia-Pacific Sales Ulcerative Colitis Market Forecast (2018-2023)

Figure South America Sales Ulcerative Colitis Market Forecast (2018-2023)

Figure Middle East and Africa Sales Ulcerative Colitis Market Forecast (2018-2023)

Table Global Ulcerative Colitis Sales Forecast by Type (2018-2023)

Table Global Ulcerative Colitis Market Share Forecast by Type (2018-2023)

Table Global Ulcerative Colitis Sales Forecast by Application (2018-2023)

Table Global Ulcerative Colitis Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List



【掲載企業】

Oral

Injection



【レポートのキーワード】

潰瘍性大腸炎、経口、注射、病院、ドラッグストア

★調査レポート[潰瘍性大腸炎の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8106697)販売に関する免責事項を必ずご確認ください。
★調査レポート[潰瘍性大腸炎の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆